Evidence map›Paper›PMID 30545130›Full record

ArticleJournal of personalized medicine2018

The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018.

Sophie Visvikis-Siest, Vesna Gorenjak, Maria G Stathopoulou, Alexandros M Petrelis, Georges Weryha, Christine Masson, Brigitte Hiegel, Satish Kumar, Robert Barouki, Eric Boerwinkle and 11 more

Open access · goldAbstract readConference Proceedings
In one paragraph

Article in Journal of personalized medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 6 countries.

Sophie Visvikis-SiestUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. sophie.visvikis-siest@inserm.fr.
Vesna GorenjakUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. vesna.gorenjak@inserm.fr.
Maria G StathopoulouUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. maria.stathopoulou@inserm.fr.
Alexandros M PetrelisUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. apetrelis@live.com.
Georges WeryhaUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. g.weryha@chru-nancy.fr.
Christine MassonUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. christine.masson@univ-lorraine.fr.
Brigitte HiegelUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. brigitte.hiegel@univ-lorraine.fr.
Satish KumarUniversité de Lorraine, Inserm, IGE-PCV, 54000 Nancy, France. satish.kumar@univ-lorraine.fr.
Robert BaroukiINSERM UMR-S 1124, Université Paris Descartes, Université Sorbonne Paris Cité, 75270 Paris, France. robert.barouki@parisdescartes.fr.
Eric BoerwinkleDepartment of Epidemiology, Human Genetics and Environmental Sciences, UTHealth School of Public Health, Houston, TX 77030, USA. Eric.Boerwinkle@uth.tmc.edu.
Georges DagherInserm UMR-S 1124, Paris-Descartes University, 75270 Paris, France. georges.dagher@inserm.fr.
Panagiotis DeloukasDepartment of Clinical Pharmacology, Queen Mary University of London, London E1 4NS, UK. p.deloukas@qmul.ac.uk.
Federico InnocentiPharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, NC 27599-2200, USA. innocent@email.unc.edu.
John LamontRandox Laboratories Ltd., Crumlin, County Antrim BT29 4XL, UK. john.lamont@randox.com.
Michael MarschlerPRAHealthSciences, 68165 Mannheim, Germany. marschlermichael@prahs.com.
Heiko MeyerAgena Bioscience GmbH, 22761 Hamburg, Germany. heiko.meyer@agenabio.com.
Urs A MeyerBiozentrum, University of Basel, 4056 Basel, Switzerland. urs-a.meyer@unibas.ch.
Charity NofzigerPharmGenetix Gmbh, 1090 Vienna, Austria. charity.nofziger@pharmgenetix.com.
Markus PaulmichlCenter for Health & Bioresources, Austrian Institute of Technology, 1210 Vienna, Austria. paulmichl@me.com.
Cora VacherIllumina, 81669 Munich, Germany. cvacher@illumina.com.
Lynn WebsterPRAHealthSciences, Salt Lake City, UT 84124, USA. WebsterLynn@prahs.com.
Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire · FRDélégation Paris 5 · FRAustrian Institute of Technology · ATPRA Health Sciences · USQueen Mary University of London · GBRandox (United Kingdom) · GBUniversity of Basel · CHUniversity of North Carolina at Chapel Hill · USUniversity of Texas Health Science Center at Dallas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 9th traditional biannual conference on Systems Medicine, Personalised Health & Therapy-"The Odyssey from Hope to Practice", inspired by the Greek mythology, was a call to search for practical solutions in cardio-metabolic diseases and cancer, to resolve and overcome the obstacles in modern medicine by creating more interactions among disciplines, as well as between academic and industrial research, directed towards an effective 'roadmap' for personalised health and therapy. The 9th Santorini Conference, under the Presidency of Sofia Siest, the director of the INSERM U1122; IGE-PCV (www.u1122.inserm.fr), University of Lorraine, France, offered a rich and innovative scientific program. It gathered 34 worldwide distinguished speakers, who shared their passion for personalised medicine with 160 attendees in nine specific sessions on the following topics: First day: The Odyssey from hope to practice: Personalised medicine-landmarks and challenges Second day: Diseases to therapeutics-genotype to phenotype an "-OMICS" approach: focus on personalised therapy and precision medicine Third day: Gene-environment interactions and pharmacovigilance: a pharmacogenetics approach for deciphering disease "bench to clinic to reality" Fourth day: Pharmacogenomics to drug discovery: a big data approach and focus on clinical data and clinical practice. In this article we present the topics shared among the participants of the conference and we highlight the key messages.

Indexed as

cancercardio-metabolic diseasesclinical trialsgenetic screening“-OMICs” biomarkerspersonalised medicinepharmacogenomicssantorini conferencesystems medicine

Identifiers

PMID30545130
PMCPMC6313418
OpenAlexW2905242976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.